Candriam Equities L Oncology Impact PI/ LU1864483836 /
| NAV16.05.2024 | Diff.+2.4500 | Ertragstyp | Ausrichtung | Fondsgesellschaft |
|---|---|---|---|---|
| 2'565.5000USD | +0.10% | thesaurierend | Aktien weltweit | Candriam ▶ |
Monatliche Performance
| Jan | Feb | Mär | Apr | Mai | Jun | Jul | Aug | Sep | Okt | Nov | Dez | Gesamt | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | - | - | 2.70 | -3.61 | -2.53 | 8.73 | 0.34 | -0.24 | -3.14 | 5.14 | 8.00 | 5.07 | - |
| 2020 | -1.43 | -5.31 | -3.03 | 12.16 | 8.58 | 1.46 | 4.47 | 2.19 | 3.55 | -2.17 | 5.86 | 3.90 | +33.03% |
| 2021 | 0.58 | -4.17 | -0.05 | 2.37 | 0.21 | 3.57 | -0.93 | 5.62 | -3.73 | 3.41 | -6.33 | 4.03 | +3.90% |
| 2022 | -10.46 | -1.72 | 4.69 | -5.82 | -1.29 | 0.08 | 4.40 | -3.10 | -4.68 | 7.08 | 6.11 | -3.41 | -9.27% |
| 2023 | 2.20 | -3.85 | 1.42 | 2.86 | -2.52 | 0.12 | 0.93 | -1.98 | -5.21 | -6.32 | 9.26 | 5.77 | +1.56% |
| 2024 | 1.41 | 4.18 | 1.53 | -3.34 | 5.02 | - | - | - | - | - | - | - | - |
Kennzahlen
| lfd. Jahr | 6 Monate | 1 Jahr | 3 Jahre | 5 Jahre | |
|---|---|---|---|---|---|
| Volatilität | 10.88% | 10.93% | 11.80% | 14.67% | 17.25% |
| Sharpe Ratio | 2.03 | 3.57 | 0.33 | -0.12 | 0.43 |
| Bester Monat | +5.77% | +9.26% | +9.26% | +9.26% | +12.16% |
| Schlechtester Monat | -3.34% | -3.34% | -6.32% | -10.46% | -10.46% |
| Maximaler Verlust | -6.73% | -6.73% | -15.73% | -24.42% | -24.42% |
| Outperformance | +16.58% | - | +23.21% | - | - |
Alle Kurse in USD
Tranchen
| Titel | Ertragstyp | Rückn. Preis | 1 Jahr | 3 Jahre | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | thesaurierend | 2'400.9099 | +7.62% | +6.05% | |
| Candriam Equities L Oncology Imp... | thesaurierend | 2'565.5000 | +7.75% | +6.45% | |
| Candriam Equities L Oncology Imp... | thesaurierend | 207.9700 | +4.02% | -4.87% | |
| Candriam Equities L Oncology Imp... | thesaurierend | 2'252.5000 | +5.81% | +17.09% | |
| Candriam Equities L Oncology Imp... | ausschüttend | 1'611.3000 | +7.27% | +5.03% | |
| Candriam Equities L Oncology Imp... | thesaurierend | 245.4500 | +6.23% | +14.09% | |
| Candriam Equities L Oncology Imp... | ausschüttend | 236.2900 | +6.27% | +2.13% | |
| Candriam Equities L Oncology Imp... | ausschüttend | 191.3300 | +7.17% | +4.73% | |
| Candriam Equities L Oncology Imp... | ausschüttend | 20'796.0000 | +3.23% | +2.32% | |
| Candriam Equities L Oncology Imp... | thesaurierend | 159.3600 | +5.69% | +16.70% | |
| Candriam Equities L Oncology Imp... | thesaurierend | 2'114.3201 | +5.00% | -2.15% | |
| Candriam Equities L Oncology Imp... | thesaurierend | 260.0600 | +7.14% | +17.01% | |
| Candriam Equities L Oncology Imp... | thesaurierend | 207.4600 | +3.60% | -5.99% | |
| Candriam Equities L Oncology Imp... | thesaurierend | 286.8900 | +7.16% | +4.72% | |
| Candriam Equities L Oncology Imp... | thesaurierend | 194.1900 | +4.88% | - | |
| Candriam Equities L Oncology Imp... | thesaurierend | 1'857.8800 | +6.15% | - | |
| Candriam Equities L Oncology Imp... | thesaurierend | 2'884.1399 | +7.27% | +5.03% | |
| Candriam Equities L Oncology Imp... | thesaurierend | 157.8100 | - | - | |
| Candriam Equities L Oncology Imp... | thesaurierend | 274.5300 | +6.26% | +2.11% |
Performance
| lfd. Jahr | +8.88% | ||
|---|---|---|---|
| 6 Monate | +19.33% | ||
| 1 Jahr | +7.75% | ||
| 3 Jahre | +6.45% | ||
| 5 Jahre | +69.82% | ||
| 10 Jahre | - | ||
| seit Beginn | +70.28% | ||
| Jahr | |||
| 2023 | +1.56% | ||
| 2022 | -9.27% | ||
| 2021 | +3.90% | ||
| 2020 | +33.03% | ||
